BLACK DIAMOND THERAPEUTICS, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 202[●] Subordinated Debt SecuritiesIndenture • February 1st, 2021 • Black Diamond Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 1st, 2021 Company Industry JurisdictionINDENTURE, dated as of [●], 202 , among BLACK DIAMOND THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
OPEN MARKET SALE AGREEMENTSMOpen Market Sale Agreement • February 1st, 2021 • Black Diamond Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 1st, 2021 Company Industry Jurisdiction